A 10-month longitudinal household study of pre-school children and their families was undertaken with monthly visits collecting epidemiological data and nasopharyngeal swabs in Hertfordshire, England from 2001 to 2002. Pneumococcal culture was with standard methods. In total, 121 families (489 individuals) took part. Mean prevalence of carriage ranged from 52% for age groups 0-2 years, 45% for 3-4 years, 21% for 5-17 years and 8% for ≥18 years. Carriage occurred more than once in 86% of children aged 0-2 years compared to 36% of those aged ≥18 years. The most prevalent serotypes in the 0-2 years age group were 6B followed by 19F, 23F, 6A and 14. Young children were responsible for the majority of introductions of new serotypes into a househ...
In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the infant immunisa...
Background: During the past decades Streptococcus pneumoniae has developed significant resistance to...
Background. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...
A 10-month longitudinal household study of pre-school children and their families was undertaken wit...
A 10-month longitudinal household study of pre-school children and their families was undertaken wit...
ABSTRACTNasopharyngeal carriage is a major factor in the transmission of pneumococcal disease. The a...
Streptococcus pneumoniae is a common cause of infectious diseases such as pneumonia and sepsis. Its ...
Using nasopharyngeal carriage as a marker of vaccine impact, pneumococcal colonization and its relat...
Using nasopharyngeal carriage as a marker of vaccine impact, pneumococcal colonization and its relat...
Using nasopharyngeal carriage as a marker of vaccine impact, pneumococcal colonization and its relat...
Objective: To estimate the prevalence of nasopharyngeal (NP) carriage of pneumococcus (Streptococcus...
Abstract Background Streptococcus pneumoniae (pneumococcus) causes a wide range of clinical manifest...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...
SummaryChildren with sickle cell disease (SCD) are at high risk of severe infection with Streptococc...
In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the infant immunisa...
Background: During the past decades Streptococcus pneumoniae has developed significant resistance to...
Background. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...
A 10-month longitudinal household study of pre-school children and their families was undertaken wit...
A 10-month longitudinal household study of pre-school children and their families was undertaken wit...
ABSTRACTNasopharyngeal carriage is a major factor in the transmission of pneumococcal disease. The a...
Streptococcus pneumoniae is a common cause of infectious diseases such as pneumonia and sepsis. Its ...
Using nasopharyngeal carriage as a marker of vaccine impact, pneumococcal colonization and its relat...
Using nasopharyngeal carriage as a marker of vaccine impact, pneumococcal colonization and its relat...
Using nasopharyngeal carriage as a marker of vaccine impact, pneumococcal colonization and its relat...
Objective: To estimate the prevalence of nasopharyngeal (NP) carriage of pneumococcus (Streptococcus...
Abstract Background Streptococcus pneumoniae (pneumococcus) causes a wide range of clinical manifest...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...
SummaryChildren with sickle cell disease (SCD) are at high risk of severe infection with Streptococc...
In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the infant immunisa...
Background: During the past decades Streptococcus pneumoniae has developed significant resistance to...
Background. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...